The mode of action and clinical pharmacology of gliclazide: a review
References (117)
- et al.
Determination of serum sulphonylureas by high performance liquid chromatography with fluorimetric detection
J. Chromatogr. Biomed. Appl.
(1989) - et al.
High-performance liquid chromatographic determination of gliclazide in human plasma
J. Chromatogr.
(1987) - et al.
A binding site for (3H) glipizide in the rat cerebral cortex
Eur. J. Pharmacol.
(1987) - et al.
Pharmacokinetics of gliclazide in healthy and diabetic subjects
J. Pharm. Sci.
(1984) - et al.
The receptor for the antidiabetic sulphonylureas controls the activity of the ATP modulated K+ channel
J. Biol. Chem.
(1987) - et al.
The effect of six months gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: Role of initial CSII-induced normoglycemia
Diabetes Res. Clin. Pract.
(1991) - et al.
Vascular prostacyclin may be reduced in diabetes in man
Lancet
(1979) - et al.
Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas
Diabetes Res. Clin. Pract.
(1988) - et al.
Reduction in betathromboglobulin levels in diabetes controlled by artificial pancreas
Metabolism
(1983) - et al.
Inhibitory action of gliclazide on platelet functions
Diabetes Res. Clin. Pract.
(1989)
Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase
Thromb. Res.
(1975)
Platelet functions in diabetes mellitus
Diabetes
(1978)
Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiography
Diabetologia
(1984)
Blood rheology in diabetes mellitus
Diabetic Med.
(1990)
Structural aspects of sulphonylureas
Pharmacokinetics and metabolism of gliclazide: a review
High-performance liquid chromatographic determination of gliclazide (oral hypoglycemic agent) in serum. Attempt at sensitive fluorometric determination
Jpn. J. Clin. Path. (Rinsho Byori)
(1986)
Radioimmunoassay of gliclazide in serum. II. Changes in serum levels after oral administration
J. Jpn. Diabetes Soc. (Tongobyo)
(1982)
Study on the anti-diabetic effect of gliclazide
J. Kyoto Prof., University Med.
(1982)
Effect of dietary fibre, konjac mannan and guar gum, on absorption of sulphonylurea in man
Nutr. Rep. Int.
(1982)
The effect of timing on gliclazide absorption and action
Hiroshima J. Med. Sci.
(1990)
The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels
Eur. J. Clin. Pharmacol.
(1990)
Effects of dosing regimen of oral hypoglycemic drug, gliclazide, on blood glucose and insulin levels
Eur. J. Clin. Pharmacol.
(1989)
Drug interactions of gliclazide and other sulphonylureas in protein binding in vitro and in hypoglycaemic effects in rats
Arzneimittel-Forschung Drug Res.
(1983)
Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use
Drugs
(1989)
Interaction between gliclazide and cimetidine
Eur. J. Clin. Pharmacol.
(1987)
Enhanced sulphonylurea-induced hypoglycaemia with cimetidine
Br. J. Clin. Pharmacol.
(1983)
The metabolism of gliclazide in man
Xenobiotica
(1985)
Gliclazide metabolic clearance in debrisoquine phenotyped subjects: comparison with tolbutamide
Clin. Exp. Pharmacol. Physiol.
(1987)
Gliclazide pharmacokinetics in the elderly
Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control
Diabetic Med.
(1985)
The effects of renal disease on the pharmacokinetics of gliclazide in diabetic patients
Br. J. Clin. Pharmacol.
(1986)
Biodisposition and pharmacodynamics of gliclazide in man
The use of kinetic-dynamic interactions in the evaluation of drugs
Psychopharmacology
(1990)
Paired observations between different sulphonylureas in antidiabetic treatment
Influence of blood proteins on biomedical analysis. (II) Interaction of gliclazide with bovine serum albumin
Chem. Pharm. Bull.
(1981)
Dietary control of elderly diabetic patients — a case for review
Pract. Diabetes
(1986)
Effects of diet and gliclazide on the haemostatic system in maturity-onset diabetes
Can plasma gliclazide concentrations explain its mode of action?
A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus
Drugs
(1984)
Is sulphonylurea therapy effective long term? A 3-year study with gliclazide
Curr. Med. Res. Opin.
(1986)
HbA in long term evaluation of glycemic control
Am. J. Med.
(1991)
Evaluation of safety and efficacy of gliclazide in non-insulin-dependent diabetic patients
Bull. Int. Diabetes Fed.
(1987)
Lack of weight gain with gliclazide treatment for 30 months in type II diabetes
Curr. Med. Res. Opin.
(1984)
Comparison of diabetic control in Type 2 (non-insulin) diabetic patients treated with different sulfonylureas
Curr. Med. Res. Opin.
(1985)
Evaluation métabolique et pondérale de l'efficacité à long terme du Diamicron dans le diabète non insulino-dépendant
Vie Med.
(1982)
Treatment with gliclazide (Diamicron) in obese Nigerian diabetics
Curr. Ther. Res.
(1980)
Insulin regulation of glucogenesis in man
Diabetes
(1979)
Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview
Diabetic Med.
(1988)
Effect of gliclazide treatment on red blood cell insulin receptors, hepatic glucose production and peripheral glucose utilisation in non-insulin-dependent diabetes mellitus
Bull. Int. Diabetes Fed.
(1987)
Cited by (0)
Copyright © 1991 Published by Elsevier Ireland Ltd.